Screening for and management of other modifiable CVD risk factors are recommended in adults with hypertension.141,142 (Class 1, Level of Evidence: B-NR) 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease14 Recommendation for ASCVD Risk Assessment (Section 2.2, 2019 Prevention Guideline) For adults 40 to 75 y of age, clinicians should routinely assess traditional cardiovascular risk factors and calculate 10-y risk of ASCVD by using the pooled cohort equations (PCE).139,140,146 (Class 1, Level of Evidence: B-NR) ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; CDU, care delivery unit; CVD, cardiovascular disease; DBP, diastolic blood pressure; EHR, electronic health record; HBP, high blood pressure; MI, myocardial infarction; PCE, pooled cohort equations; QCDR, Qualified Clinical Data Registry; and SBP, systolic blood pressure. 35 Appendix A. Continued SM-3: Use of a Standard Process for Properly Screening All Adults 18 Years of Age for HBP (USPSTF) Measure Components The CDU uses a standard process/protocol for properly screening all adults 18 years of age for HBP (based on an average of 2 BP measurements), including: Adults ages 18 39 y with office-measured SBP/DBP <120/80 mmHg who do not have other hypertension risk factors can space out screenings to every 3 5 y (USPSTF).15 Annual BP screening should be done for adults at increased risk for hypertension, defined as those 40 y of age and those <40 y of age who are overweight or obese or black, regardless of age. For adults, the finding of an office BP consistent with hypertension and with SBP/DBP <160/100 mmHg at an initial visit should be confirmed at a follow-up visit within 1 month, based on an average of 2 BP measurements at each visit. 